Friday, 16 October 2026European Markets

IRISH CONT. GP. And EXEL INDUSTRIES Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(vianews) - irish cont. gp. (ir5b.ir) is among this list of stock assets with the highest dividend rate and return on equity on the industrials sector.

financial asset price forward dividend yield return on equity
irish cont. gp. (ir5b.ir) €4.85 3.04% 22.68%
exel industries (exe.pa) €55.80 2.74% 9.84%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. irish cont. gp. (ir5b.ir)

3.04% forward dividend yield and 22.68% return on equity

irish continental group plc operates as a maritime transport company. it operates through two segments, ferries, and container and terminal. the ferries segment provides ferry services carrying passengers and roll on roll off freight on short sea routes on routes between ireland, britain, and continental europe under the irish ferries brand; and chartering services. the container and terminal segment provides door-to-door and feeder lift on lift off freight services under the eucon brand, stevedoring, and other related terminal services, as well as operates container terminals in the ports of dublin and belfast. the company also provides container shipping, ship leasing, administration, and container handling services. in addition, it operates ferry; and act as a shipping and forwarding agency; as well as is involved in non-trading activities. the company was founded in 1972 and is based in dublin, ireland.

earnings per share

as for profitability, irish cont. gp. has a trailing twelve months eps of €0.36.

pe ratio

irish cont. gp. has a trailing twelve months price to earnings ratio of 13.47. meaning, the purchaser of the share is investing €13.47 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.68%.

volume

today's last reported volume for irish cont. gp. is 669258 which is 222.49% above its average volume of 207524.

revenue growth

year-on-year quarterly revenue growth declined by 4.3%, now sitting on 572m for the twelve trailing months.

moving average

irish cont. gp.'s worth is above its 50-day moving average of €4.63 and above its 200-day moving average of €4.56.

more news about irish cont. gp..

2. exel industries (exe.pa)

2.74% forward dividend yield and 9.84% return on equity

exel industries sa engages in the manufacture and sale of agricultural spraying equipment worldwide. the company provides garden watering and spraying equipment; industrial spraying equipment; and leisure and garden equipment. it offers sugar beet harvesters; sugar beet loading machinery and carrier tractors; technical hoses; ocean-going yachts, prestigious day-sailers, and neo-classic fishing and open powerboats. the company markets its products under the hardi, evrard, berthoud, tecnoma, nicolas, matrot, cmc, agrifac, exxact robotics, gf, apache, wauquiez, rhéa marine, tofinou, hozelock, laser, holmer, sames, tricoflex, and cooper pegler brands. exel industries sa was incorporated in 1952 and is headquartered in paris, france.

earnings per share

as for profitability, exel industries has a trailing twelve months eps of €6.3.

pe ratio

exel industries has a trailing twelve months price to earnings ratio of 8.86. meaning, the purchaser of the share is investing €8.86 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.84%.

revenue growth

year-on-year quarterly revenue growth grew by 7.2%, now sitting on 1.09b for the twelve trailing months.

volume

today's last reported volume for exel industries is 755 which is 6.63% above its average volume of 708.

more news about exel industries.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com